Tolvaptan Patent Expiration
Tolvaptan is Used for treating low levels of sodium in the blood (hyponatremia). It was first introduced by Otsuka Pharmaceutical Co Ltd
Tolvaptan Patents
Given below is the list of patents protecting Tolvaptan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Jynarque | US10905694 | Pharmaceutical solid preparation comprising benzazepines and production method thereof | Apr 07, 2030 | Otsuka |
| Samsca | US10905694 | Pharmaceutical solid preparation comprising benzazepines and production method thereof | Apr 07, 2030 | Otsuka |
| Jynarque | US8501730 | Process for preparing benzazepine compounds or salts thereof | Sep 01, 2026 | Otsuka |
| Samsca | US8501730 | Process for preparing benzazepine compounds or salts thereof | Sep 01, 2026 | Otsuka |
| Jynarque | US5753677 | Benzoheterocyclic compounds |
May 19, 2020
(Expired) | Otsuka |
| Jynarque | US5972882 | Treatment of polycystic kidney disease using vasopressin V2 receptor antagonists |
Dec 14, 2018
(Expired) | Otsuka |
| Samsca | US5753677 | Benzoheterocyclic compounds |
May 19, 2015
(Expired) | Otsuka |
| Samsca | US5258510 | Benzoheterocyclic compounds |
Nov 02, 2012
(Expired) | Otsuka |
Tolvaptan's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List